Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Caprolactam Chemicals has informed that a meeting of the Board of Directors of the Company will be held on Friday, 13th February, 2026 at 4.00 pm, to consider and approve the unaudited financial results of the Company for the Quarter ended December 31st, 2025 and to recommend payment of dividend on equity shares, if any. Further, as notified by the Company vide letter dated January 1st, 2026, pursuant to the Company’s code to regulate, monitor and report trading by Insiders, the Trading Window Close Period for dealing in the securities of the Company for all the Designated Persons and their relatives has commenced from January 1st, 2026 and will remain close till 48 hours after the declaration of aforesaid financial results.
The above information is a part of company’s filings submitted to BSE.
